Page 2 - Fierce Medtech News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Jun 14, 2021 7:01pm Ada Health’s smartphone app, which uses artificial intelligence to analyze a user’s self-reported symptoms and suggest a list of potential causes, has already attracted plenty of attention from Big Pharma, including a Bayer-led series B and a recently expanded collaboration with Novartis. (Ada Health) Typically, when pharmaceutical companies turn to medtech developers for support, they’re in the market to boost their drug discovery and development capabilities with the help of a shiny new artificial intelligence tool or to deploy a smartphone app to monitor t...

Kajeet Director of Strategy Dominic Marcellino to Deliver Partner Keynote at Fierce MedTech Innovation Week on April 26, 2021 Share Article Marcellino will join medical industry experts for a virtual discussion on how the telehealth revolution is transforming healthcare MCLEAN, Va. (PRWEB) April 20, 2021 WHAT The rise of IoT and connected devices that facilitate data streaming are helping healthcare providers trailblaze new care delivery models outside of traditional clinical settings, such as remote patient monitoring and digit...

Apr 5, 2021 3:30pm Inscripta’s latest funding round will support the development and distribution of its Onyx benchtop platform, which uses CRISPR gene editing technology for fully automated genomic engineering. (AstraZeneca) Inscripta just got another step closer to achieving its mission of bringing CRISPR gene editing technology to the scientific masses. The genomic engineering company, a member of Fierce Medtech’s 2019 Fierce 15, recently closed a series E funding round totaling $150 million. The investment was led by Fidelity Management and Research Company and funds and accou...

Press release content from Business Wire. The AP news staff was not involved in its creation. Babson Diagnostics Named Fierce MedTech “Fierce 15” Company March 9, 2021 GMT AUSTIN, Texas--(BUSINESS WIRE)--Mar 9, 2021-- Babson Diagnostics (Babson), a transformative medical technology company improving customer access to diagnostic blood testing, was named one of Fierce Medtech’s elite “Fierce 15.” The honor recognizes Babson as one of the most promising private companies in the global healthcare industry. In the year of COVID-19, Fierce Medtech, a leading daily digital news publicatio...

Fierce Medtech names Caption Health as one of its "Fierce 15" companies of 2020 Caption Health recognized for its innovative AI-guided, FDA-cleared cardiac ultrasound software News provided by Share this article Share this article BRISBANE, Calif., March 8, 2021 /PRNewswire/ -- Caption Health today announced that it has been named by Fierce Medtech as one of 2020's Fierce 15, designating it as one of the most promising private companies in the industry. (PRNewsfoto/Caption Health) Caption Health's flagship product Caption AI is the first and only AI-guided medical imaging acquisition softwar...